ADVANCED ENDOMETRIAL CANCER
Clinical trials for ADVANCED ENDOMETRIAL CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED ENDOMETRIAL CANCER trials appear
Sign up with your email to follow new studies for ADVANCED ENDOMETRIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New IgE antibody trial targets Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase trial tests a new drug called MOv18 IgE in people with advanced ovarian, endometrial, or triple-negative breast cancers that have a specific marker (folate receptor alpha). The study has two parts: first, finding the safest dose, then checking how well it works. …
Matched conditions: ADVANCED ENDOMETRIAL CANCER
Phase: PHASE1 • Sponsor: Epsilogen Ltd • Aim: Disease control
Last updated Jun 16, 2026 22:22 UTC
-
New hope for advanced endometrial cancer: immune drug combo tested
Disease control Recruiting nowThis study tests a new drug, envafolimab, given alone or with lenvatinib, in people with advanced endometrial cancer that has spread or returned after standard chemotherapy. The goal is to see if the treatment shrinks tumors. About 108 adults who have failed or cannot tolerate fi…
Matched conditions: ADVANCED ENDOMETRIAL CANCER
Phase: PHASE2 • Sponsor: 3D Medicines (Sichuan) Co., Ltd. • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC